{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:20:51Z","timestamp":1782955251393,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2021]]},"DOI":"10.6061\/clinics\/2021\/e2380","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:25:05Z","timestamp":1611127505000},"page":"e2380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of Raloxifene Combined with Low-dose Conjugated Estrogen on the Endometrium in Menopausal Women at High Risk for Breast Cancer"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-0674","authenticated-orcid":false,"given":"Andrea Lucia Bastos","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4734-6872","authenticated-orcid":false,"given":"Ana Paula Curi","family":"Spadella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2406-0783","authenticated-orcid":false,"given":"Fabiola Amaral de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-2706","authenticated-orcid":false,"given":"Karen Borelli Ferreira","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-393X","authenticated-orcid":false,"given":"Joaquim Teodoro de","family":"Araujo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2643-6091","authenticated-orcid":false,"given":"Mauro Abi","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8642-4135","authenticated-orcid":false,"given":"Rita de C\u00e1ssia de Maio","family":"Dardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.6061\/clinics\/2021\/e2380_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","author":"The NAMS 2017 Hormone Therapy Position Statement Adisory Panel","year":"2017","journal-title":"Menopause"},{"key":"10.6061\/clinics\/2021\/e2380_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/978-3-642-59945-3_7","article-title":"Development of a new prevention maintenance therapy for postmenopausal women","volume":"151","author":"Jordan","year":"1999","journal-title":"Recent Results Cancer Res"},{"issue":"17","key":"10.6061\/clinics\/2021\/e2380_bib3","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1158\/1078-0432.CCR-06-1136","article-title":"The science of selective estrogen receptor modulators: concept to clinical practice","volume":"12","author":"Jordan","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2380_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1258\/0007142001903355","article-title":"Novel agents to modulate oestrogen action","volume":"56","author":"Dardes","year":"2000","journal-title":"Br Med Bull"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2380_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/OGX.0b013e31828baef9","article-title":"Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications","volume":"68","author":"Gizzo","year":"2013","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"10.6061\/clinics\/2021\/e2380_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2380_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","article-title":"The NSABP Study of Tamoxifen and Raloxifene (STAR) trial","volume":"9","author":"Vogel","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"23","key":"10.6061\/clinics\/2021\/e2380_bib8","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.6061\/clinics\/2021\/e2380_bib9","author":"National Cancer Institute"},{"issue":"23","key":"10.6061\/clinics\/2021\/e2380_bib10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2380_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00042192-199704020-00004","article-title":"Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0.3mg of unopposed esterified estrogens","volume":"4","author":"Notelovitz","year":"1997","journal-title":"Menopause"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2380_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13697130008500107","article-title":"Low-dose esterified estrogens (0.3 mg\/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women","volume":"3","author":"Rebar","year":"2000","journal-title":"Climacteric"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2380_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.6061\/clinics\/2021\/e2380_bib14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy - the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.6061\/clinics\/2021\/e2380_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2013.12.011","article-title":"Use of SERMs for treatment in postmenopausal women","volume":"142","author":"Pinkerton","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2380_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1933719112463251","article-title":"Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells","volume":"20","author":"Kulak","year":"2013","journal-title":"Reprod Sci"},{"issue":"1-3","key":"10.6061\/clinics\/2021\/e2380_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsbmb.2008.09.002","article-title":"Effects of selective oestrogen receptor modulators on proliferation in tissue cultures of pre- and postmenopausal human endometrium","volume":"112","author":"Punyadeera","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2380_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00795-008-0403-1","article-title":"Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells","volume":"41","author":"Morishima","year":"2008","journal-title":"Med Mol Morphol"},{"issue":"10","key":"10.6061\/clinics\/2021\/e2380_bib19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/molehr\/gap045","article-title":"Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells","volume":"15","author":"Flamini","year":"2009","journal-title":"Mol Hum Reprod"},{"issue":"1-3","key":"10.6061\/clinics\/2021\/e2380_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2008.06.091","article-title":"Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model","volume":"592","author":"Bl\u00e4uer","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2380_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S0100-72032006000200005","article-title":"Efeitos da terapia estro-raloxifeno sobre o endom\u00e9trio de ratas","volume":"28","author":"Moraes","year":"2006","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2380_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jnci\/94.4.274","article-title":"Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice","volume":"94","author":"O\u2019Regan","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2380_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/13697137.2011.624213","article-title":"The effects of conjugated estrogen, raloxifene and soy extract on collagen in rat bones","volume":"15","author":"Condi","year":"2012","journal-title":"Climacteric"},{"issue":"3-5","key":"10.6061\/clinics\/2021\/e2380_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsbmb.2011.05.001","article-title":"The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk","volume":"126","author":"Williams-Brown","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2-3","key":"10.6061\/clinics\/2021\/e2380_bib25","first-page":"93","article-title":"Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses","volume":"52","author":"Carranza-Lira","year":"2007","journal-title":"Int J Fertil Womens Med"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2380_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2008.10.013","article-title":"Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium - a randomized controlled trial","volume":"62","author":"Valiati","year":"2009","journal-title":"Maturitas"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2380_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.GME.0000087981.28957.CF","article-title":"Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium - a pilot study","volume":"11","author":"Davis","year":"2004","journal-title":"Menopause"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2380_bib28","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women","volume":"10","author":"Pinkerton","year":"2003","journal-title":"Menopause"},{"issue":"3 Pt 1","key":"10.6061\/clinics\/2021\/e2380_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/GME.0b013e318031a83d","article-title":"The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety","volume":"14","author":"Stovall","year":"2007","journal-title":"Menopause"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2380_bib30","first-page":"218","article-title":"Histological study of the endometrium in menopausal women with breast carcinoma","volume":"10","author":"Naz\u00e1rio","year":"1992","journal-title":"Rev Paul Med"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2380_bib31","first-page":"104","article-title":"Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60","volume":"95","author":"Cohen","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.6061\/clinics\/2021\/e2380_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/gme.0b013e31824a74ce","article-title":"Estrogens plus raloxifene on endometrial safety and menopausal symptoms-semisystematic review","volume":"19","author":"Carneiro","year":"2012","journal-title":"Menopause"},{"issue":"Suppl 12B","key":"10.6061\/clinics\/2021\/e2380_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjmed.2005.09.035","article-title":"Vasomotor symptom relief versus unwanted effects: role of estrogen dosage","volume":"118","author":"Ettinger","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2380_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajog.2009.02.006","article-title":"The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium","volume":"201","author":"Goldstein","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:05:40Z","timestamp":1761721540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222000977"},"secondary":[{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322021000100214&lng=en&nrm=iso","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7798121\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/effects-of-raloxifene-combined-with-low-dose-conjugated-estrogen-on-the-endometrium-in-menopausal-women-at-high-risk-for-breast-cancer\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":34,"alternative-id":["S1807593222000977"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2380","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Raloxifene Combined with Low-dose Conjugated Estrogen on the Endometrium in Menopausal Women at High Risk for Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e2380"}}